These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 23595627)
1. ZIP4 is a novel molecular marker for glioma. Lin Y; Chen Y; Wang Y; Yang J; Zhu VF; Liu Y; Cui X; Chen L; Yan W; Jiang T; Hergenroeder GW; Fletcher SA; Levine JM; Kim DH; Tandon N; Zhu JJ; Li M Neuro Oncol; 2013 Aug; 15(8):1008-16. PubMed ID: 23595627 [TBL] [Abstract][Full Text] [Related]
2. Expression Profile Analysis of Zinc Transporters (ZIP4, ZIP9, ZIP11, ZnT9) in Gliomas and their Correlation with IDH1 Mutation Status. Kang X; Chen R; Zhang J; Li G; Dai PG; Chen C; Wang HJ Asian Pac J Cancer Prev; 2015; 16(8):3355-60. PubMed ID: 25921144 [TBL] [Abstract][Full Text] [Related]
3. HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Zhang JX; Han L; Bao ZS; Wang YY; Chen LY; Yan W; Yu SZ; Pu PY; Liu N; You YP; Jiang T; Kang CS; Neuro Oncol; 2013 Dec; 15(12):1595-603. PubMed ID: 24203894 [TBL] [Abstract][Full Text] [Related]
4. Expression level of human miR-34a correlates with glioma grade and prognosis. Gao H; Zhao H; Xiang W J Neurooncol; 2013 Jun; 113(2):221-8. PubMed ID: 23529798 [TBL] [Abstract][Full Text] [Related]
5. High CHI3L1 expression is associated with glioma patient survival. Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858 [TBL] [Abstract][Full Text] [Related]
6. Tumor microRNA-335 expression is associated with poor prognosis in human glioma. Jiang J; Sun X; Wang W; Jin X; Bo X; Li Z; Bian A; Jiu J; Wang X; Liu D; Hui X; Wang Y; Wang A; Ding L Med Oncol; 2012 Dec; 29(5):3472-7. PubMed ID: 22644918 [TBL] [Abstract][Full Text] [Related]
7. ACTC1 as an invasion and prognosis marker in glioma. Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897 [TBL] [Abstract][Full Text] [Related]
8. Oncogenic reg IV is a novel prognostic marker for glioma patient survival. Wang Q; Deng J; Yuan J; Wang L; Zhao Z; He S; Zhang Y; Tu Y Diagn Pathol; 2012 Jun; 7():69. PubMed ID: 22713481 [TBL] [Abstract][Full Text] [Related]
9. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas. Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L Front Immunol; 2020; 11():603341. PubMed ID: 33363544 [TBL] [Abstract][Full Text] [Related]
10. The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas. Cooper LA; Gutman DA; Long Q; Johnson BA; Cholleti SR; Kurc T; Saltz JH; Brat DJ; Moreno CS PLoS One; 2010 Sep; 5(9):e12548. PubMed ID: 20838435 [TBL] [Abstract][Full Text] [Related]
11. An integrated transcriptomic and computational analysis for biomarker identification in human glioma. Xing W; Zeng C Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173 [TBL] [Abstract][Full Text] [Related]
12. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma. Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773 [TBL] [Abstract][Full Text] [Related]
13. cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome. Odia Y; Orr BA; Bell WR; Eberhart CG; Rodriguez FJ J Neurooncol; 2013 Nov; 115(2):249-59. PubMed ID: 23934175 [TBL] [Abstract][Full Text] [Related]
14. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation. Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of zinc transporter ZIP4, ZIP11, ZnT1, and ZnT6 predicts poor prognosis in pancreatic cancer. Zhu B; Huo R; Zhi Q; Zhan M; Chen X; Hua ZC J Trace Elem Med Biol; 2021 May; 65():126734. PubMed ID: 33631610 [TBL] [Abstract][Full Text] [Related]
16. Molecular genetic profiling reveals novel association between FLT3 mutation and survival in glioma. Shee K; Chambers M; Hughes EG; Almiron DA; Deharvengt SJ; Green D; Lefferts JA; Andrew AS; Hickey WF; Tsongalis GJ J Neurooncol; 2020 Jul; 148(3):473-480. PubMed ID: 32583303 [TBL] [Abstract][Full Text] [Related]
17. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma. Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539 [TBL] [Abstract][Full Text] [Related]
18. High expression of forkhead box protein C2 is related to poor prognosis in human gliomas. Wang YW; Yin CL; Zhang HY; Hao J; Yang YY; Liao H; Jiao BH Asian Pac J Cancer Prev; 2014; 15(24):10621-5. PubMed ID: 25605149 [TBL] [Abstract][Full Text] [Related]
19. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas. Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164 [TBL] [Abstract][Full Text] [Related]
20. MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas. Hermansen SK; Dahlrot RH; Nielsen BS; Hansen S; Kristensen BW J Neurooncol; 2013 Jan; 111(1):71-81. PubMed ID: 23104517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]